159 related articles for article (PubMed ID: 7493005)
1. Does bacitracin have an absorption-enhancing effect in the intestine?
Gotoh S; Nakamura R; Nishiyama M; Fujita T; Yamamoto A; Muranishi S
Biol Pharm Bull; 1995 May; 18(5):794-6. PubMed ID: 7493005
[TBL] [Abstract][Full Text] [Related]
2. Effects of protease inhibitors on the absorption of phenol red and fluorescein isothiocyanate dextrans from the rat intestine.
Gotoh S; Nakamura R; Nishiyama M; Quan YS; Fujita T; Yamamoto A; Muranishi S
J Pharm Sci; 1996 Aug; 85(8):858-62. PubMed ID: 8863277
[TBL] [Abstract][Full Text] [Related]
3. Effects of various protease inhibitors on the intestinal absorption and degradation of insulin in rats.
Yamamoto A; Taniguchi T; Rikyuu K; Tsuji T; Fujita T; Murakami M; Muranishi S
Pharm Res; 1994 Oct; 11(10):1496-500. PubMed ID: 7855059
[TBL] [Abstract][Full Text] [Related]
4. Alleviation by garlic of antitumor drug-induced damage to the intestine.
Horie T; Awazu S; Itakura Y; Fuwa T
J Nutr; 2001 Mar; 131(3s):1071S-4S. PubMed ID: 11238819
[TBL] [Abstract][Full Text] [Related]
5. Absorption characteristics of model compounds from the small intestinal serosal surface and a comparison with other organ surfaces.
Nishida K; Kuma A; Fumoto S; Nakashima M; Sasaki H; Nakamura J
J Pharm Pharmacol; 2005 Aug; 57(8):1073-7. PubMed ID: 16102265
[TBL] [Abstract][Full Text] [Related]
6. Use of protease inhibitors to improve calcitonin absorption from the small and large intestine in rats.
Tozaki H; Odoriba T; Iseki T; Taniguchi T; Fujita T; Murakami M; Muranishi S; Yamamoto A
J Pharm Pharmacol; 1998 Aug; 50(8):913-20. PubMed ID: 9751457
[TBL] [Abstract][Full Text] [Related]
7. Estimation of absorption enhancement by medium-chain fatty acids in rat large intestine.
Higaki K; Yata T; Sone M; Ogawara K; Kimura T
Res Commun Mol Pathol Pharmacol; 2001; 109(3-4):231-40. PubMed ID: 11758652
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress and enhanced paracellular permeability in the small intestine of methotrexate-treated rats.
Maeda T; Miyazono Y; Ito K; Hamada K; Sekine S; Horie T
Cancer Chemother Pharmacol; 2010 May; 65(6):1117-23. PubMed ID: 19756603
[TBL] [Abstract][Full Text] [Related]
9. Improvement of intestinal absorption of water-soluble macromolecules by various polyamines: intestinal mucosal toxicity and absorption-enhancing mechanism of spermine.
Gao Y; He L; Katsumi H; Sakane T; Fujita T; Yamamoto A
Int J Pharm; 2008 Apr; 354(1-2):126-34. PubMed ID: 18206325
[TBL] [Abstract][Full Text] [Related]
10. Electrophysiological studies on the mechanism for enhanced intestinal transport of water-soluble compounds by antibiotic peptide bacitracin.
Quan YS; Kuribayashi D; Nakamoto Y; Doi M; Muranishi S; Fujita T; Yamamoto A
Biol Pharm Bull; 1999 Aug; 22(8):841-5. PubMed ID: 10480323
[TBL] [Abstract][Full Text] [Related]
11. [Effects of protease inhibitors on intestinal absorption of insulin].
Liu H; Pan WS; Du R; Li XD; Tang R
Yao Xue Xue Bao; 2004 Feb; 39(2):140-3. PubMed ID: 15127624
[TBL] [Abstract][Full Text] [Related]
12. Improvement of intestinal absorption of macromolecules by nitric oxide donor.
Numata N; Takahashi K; Mizuno N; Utoguchi N; Watanabe Y; Matsumoto M; Mayumi T
J Pharm Sci; 2000 Oct; 89(10):1296-304. PubMed ID: 10980504
[TBL] [Abstract][Full Text] [Related]
13. Intestinal permeability enhancement: structure-activity and structure-toxicity relationships for nonylphenoxypolyoxyethylene surfactant permeability enhancers.
Swenson ES; Milisen WB; Curatolo W
Pharm Res; 1994 Oct; 11(10):1501-4. PubMed ID: 7855060
[No Abstract] [Full Text] [Related]
14. Effectiveness and toxicity screening of various absorption enhancers in the rat small intestine: effects of absorption enhancers on the intestinal absorption of phenol red and the release of protein and phospholipids from the intestinal membrane.
Yamamoto A; Uchiyama T; Nishikawa R; Fujita T; Muranishi S
J Pharm Pharmacol; 1996 Dec; 48(12):1285-9. PubMed ID: 9004192
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness and toxicity screening of various absorption enhancers using Caco-2 cell monolayers.
Quan YS; Hattori K; Lundborg E; Fujita T; Murakami M; Muranishi S; Yamamoto A
Biol Pharm Bull; 1998 Jun; 21(6):615-20. PubMed ID: 9657048
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of intestinal absorption of poorly absorbed hydrophilic compounds by simultaneous use of mucolytic agent and non-ionic surfactant.
Takatsuka S; Kitazawa T; Morita T; Horikiri Y; Yoshino H
Eur J Pharm Biopharm; 2006 Jan; 62(1):52-8. PubMed ID: 16289777
[TBL] [Abstract][Full Text] [Related]
17. Absorption characteristics of model compounds with different molecular weights from the serosal caecal surface in rats.
Nishida K; Nose S; Kuma A; Mukai T; Kawakami S; Nakashima M; Sasaki H; Sakaeda T; Nakamura J
J Pharm Pharmacol; 2002 Jul; 54(7):1005-9. PubMed ID: 12162704
[TBL] [Abstract][Full Text] [Related]
18. Absorption enhancing effects of chitosan oligomers on the intestinal absorption of low molecular weight heparin in rats.
Zhang H; Mi J; Huo Y; Huang X; Xing J; Yamamoto A; Gao Y
Int J Pharm; 2014 May; 466(1-2):156-62. PubMed ID: 24614577
[TBL] [Abstract][Full Text] [Related]
19. Intestinal macromolecular transmission in the young rat: influence of protease inhibitors during development.
Telemo E; Weström BR; Ekström G; Karlsson BW
Biol Neonate; 1987; 52(3):141-8. PubMed ID: 2443191
[TBL] [Abstract][Full Text] [Related]
20. Effects of various absorption promoters on pulmonary absorption of drugs with different molecular weights.
Morita T; Yamamoto A; Hashida M; Sezaki H
Biol Pharm Bull; 1993 Mar; 16(3):259-62. PubMed ID: 7689890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
